Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
If a research goal has not changed by earlier review points, adding more time does not have a proven benefit
AOD-9604 is typically dosed at 250 to 300 mcg subcutaneously once daily, often injected into abdominal adipose tissue
METAOD006 tested oral AOD-9604 for 24 weeks
While early and smaller trials showed promising fat-loss effects, the largest Phase IIb trial did not achieve statistical significance in humans for its primary endpoint of weight reduction, which led to the program being discontinued
US$ 25.15
US$ 29.68
US$ 20.52
US$ 26.66
US$ 29.06
US$ 29.18
US$ 26.79
US$ 21.15
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
US$ 27.01
